Thrombotic Thrombocytopenic Purpura (TTP) – London and the South East (Kent, Surrey, East & West Sussex)
Lot No:
1
II.2.2)
Additional CPV code(s)
85100000
-
Health services
85000000
-
Health and social work services
II.2.3)
Place of performance
NUTS code:
UKJ4 -
Kent
NUTS code:
UKJ2 -
Surrey, East and West Sussex
NUTS code:
UKI -
LONDON
Main site or place of performance:
London and the South East (Kent, Surrey, East & West Sussex)
II.2.4)
Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting interested Providers to bid for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
There are patient flows to London from all over the South East. Commissioners have considered establishing one specialist provider for all of London and the South East and this is the default commissioner position.
Commissioners will consider bids for the South East (Thames Valley and Hampshire and Isle of Wight areas - (Lot 2)), to facilitate patient choice and to reduce the requirement to travel for providers who meet the criteria in the service specification, in the technical questionnaire and who are willing to work within a Clinical Partnership with the successful bidder for the London and South East Lot (Lot 1).
The contracting term for these services will be for a period of up to 4 years.
Criteria below
Quality criterion
-
Name:
Section K : Skills and competences
/
Weighting:
20
Quality criterion
-
Name:
Section L: Managing access and treatment pathway
/
Weighting:
42
Quality criterion
-
Name:
Section M: Mobilisation
/
Weighting:
10
Quality criterion
-
Name:
Section N: Education and service continuity
/
Weighting:
6
Quality criterion
-
Name:
Section O: Clinical outcomes and governance
/
Weighting:
7
Quality criterion
-
Name:
Section P: Patient satisfaction and patient group
/
Weighting:
10
Quality criterion
-
Name:
: Section Q: Networks and leadership
/
Weighting:
5
Price
-
Weighting:
0
Value excluding VAT: 20589200.00
GBP
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
48
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
II.2.14)
Additional information
Please note that Lots may have changed from previous publications.
Thrombotic Thrombocytopenic Purpura (TTP) - South East (Thames Valley, Hampshire and the Isle of Wight)
Lot No:
2
II.2.2)
Additional CPV code(s)
85000000
-
Health and social work services
85100000
-
Health services
II.2.3)
Place of performance
NUTS code:
UKJ -
SOUTH EAST (ENGLAND)
Main site or place of performance:
South East (Thames Valley, Hampshire and the Isle of Wight)
II.2.4)
Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
The contracting term for these services will be for a period of up to 4 years.
Criteria below
Quality criterion
-
Name:
Section K : Skills and competences
/
Weighting:
20
Quality criterion
-
Name:
Section L: Managing access and treatment pathway
/
Weighting:
42
Quality criterion
-
Name:
Section M: Mobilisation
/
Weighting:
10
Quality criterion
-
Name:
Section N: Education and service continuity
/
Weighting:
6
Quality criterion
-
Name:
Section O: Clinical outcomes and governance
/
Weighting:
7
Quality criterion
-
Name:
Section P: Patient satisfaction and patient group
/
Weighting:
10
Quality criterion
-
Name:
Section Q: Networks and leadership
/
Weighting:
5
Price
-
Weighting:
0
Value excluding VAT: 4173800.00
GBP
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
48
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
II.2.14)
Additional information
Please note that Lots may have changed from previous publications.
Thrombotic Thrombocytopenic Purpura (TTP) - West Midlands
Lot No:
3
II.2.2)
Additional CPV code(s)
85000000
-
Health and social work services
85100000
-
Health services
II.2.3)
Place of performance
NUTS code:
UKG -
WEST MIDLANDS (ENGLAND)
Main site or place of performance:
West Midlands
II.2.4)
Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
The contracting term for these services will be for a period of up to 4 years
Criteria below
Quality criterion
-
Name:
Section K : Skills and competences
/
Weighting:
20
Quality criterion
-
Name:
Section L: Managing access and treatment pathway
/
Weighting:
42
Quality criterion
-
Name:
Section M: Mobilisation
/
Weighting:
10
Quality criterion
-
Name:
Section N: Education and service continuity
/
Weighting:
6
Quality criterion
-
Name:
Section O: Clinical outcomes and governance
/
Weighting:
7
Quality criterion
-
Name:
Section P: Patient satisfaction and patient group
/
Weighting:
10
Quality criterion
-
Name:
Section Q: Networks and leadership
/
Weighting:
5
Price
-
Weighting:
0
Value excluding VAT: 7633000.00
GBP
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
48
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
II.2.14)
Additional information
Please note that Lots may have changed from previous publications.
Thrombotic Thrombocytopenic Purpura (TTP) - East Midlands
Lot No:
4
II.2.2)
Additional CPV code(s)
85000000
-
Health and social work services
85100000
-
Health services
II.2.3)
Place of performance
NUTS code:
UKF -
EAST MIDLANDS (ENGLAND)
Main site or place of performance:
East Midlands
II.2.4)
Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres centre in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
The contracting term for these services will be for a period of up to 4 years.
Criteria below
Quality criterion
-
Name:
Section K : Skills and competences
/
Weighting:
20
Quality criterion
-
Name:
Section L: Managing access and treatment pathway
/
Weighting:
42
Quality criterion
-
Name:
: Section M: Mobilisation
/
Weighting:
10
Quality criterion
-
Name:
Section N: Education and service continuity
/
Weighting:
6
Quality criterion
-
Name:
Section O: Clinical outcomes and governance
/
Weighting:
7
Quality criterion
-
Name:
Section P: Patient satisfaction and patient group
/
Weighting:
10
Quality criterion
-
Name:
Section Q: Networks and leadership
/
Weighting:
5
Price
-
Weighting:
0
Value excluding VAT: 4041100.00
GBP
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
48
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
II.2.14)
Additional information
Please note that Lots may have changed from previous publications.
Thrombotic Thrombocytopenic Purpura (TTP) - East of England
Lot No:
5
II.2.2)
Additional CPV code(s)
85000000
-
Health and social work services
85100000
-
Health services
II.2.3)
Place of performance
NUTS code:
UKH -
EAST OF ENGLAND
Main site or place of performance:
East of England
II.2.4)
Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
The contracting term for these services will be for a period of up to 4 years.
Criteria below
Quality criterion
-
Name:
Section K : Skills and competences
/
Weighting:
20
Quality criterion
-
Name:
Section L: Managing access and treatment pathway
/
Weighting:
42
Quality criterion
-
Name:
Section M: Mobilisation
/
Weighting:
10
Quality criterion
-
Name:
Section N: Education and service continuity
/
Weighting:
6
Quality criterion
-
Name:
Section O: Clinical outcomes and governance
/
Weighting:
7
Quality criterion
-
Name:
Section P: Patient satisfaction and patient group
/
Weighting:
10
Quality criterion
-
Name:
Section Q: Networks and leadership
/
Weighting:
5
Price
-
Weighting:
0
Value excluding VAT: 4017500.00
GBP
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
48
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
II.2.14)
Additional information
Please note that Lots may have changed from previous publications.
Thrombotic Thrombocytopenic Purpura (TTP) - North East
Lot No:
6
II.2.2)
Additional CPV code(s)
85000000
-
Health and social work services
85100000
-
Health services
II.2.3)
Place of performance
NUTS code:
UKC -
NORTH EAST (ENGLAND)
Main site or place of performance:
North East
II.2.4)
Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
The contracting term for these services will be for a period of up to 4 years.
Criteria below
Quality criterion
-
Name:
Section K : Skills and competences
/
Weighting:
20
Quality criterion
-
Name:
Section L: Managing access and treatment pathway
/
Weighting:
42
Quality criterion
-
Name:
Section M: Mobilisation
/
Weighting:
10
Quality criterion
-
Name:
Section N: Education and service continuity
/
Weighting:
6
Quality criterion
-
Name:
Section O: Clinical outcomes and governance
/
Weighting:
7
Quality criterion
-
Name:
Section P: Patient satisfaction and patient group
/
Weighting:
10
Quality criterion
-
Name:
Section Q: Networks and leadership
/
Weighting:
5
Price
-
Weighting:
0
Value excluding VAT: 40002800.00
GBP
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
48
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
II.2.14)
Additional information
Please note that Lots may have changed from previous publications.
Thrombotic Thrombocytopenic Purpura (TTP) - Yorkshire and the Humber
Lot No:
7
II.2.2)
Additional CPV code(s)
85000000
-
Health and social work services
85100000
-
Health services
II.2.3)
Place of performance
NUTS code:
UKE -
YORKSHIRE AND THE HUMBER
Main site or place of performance:
Yorkshire and the Humber
II.2.4)
Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
The contracting term for these services will be for a period of up to 4 years
Criteria below
Quality criterion
-
Name:
Section K : Skills and competences
/
Weighting:
20
Quality criterion
-
Name:
Section L: Managing access and treatment pathway
/
Weighting:
42
Quality criterion
-
Name:
Section M: Mobilisation
/
Weighting:
10
Quality criterion
-
Name:
Section N: Education and service continuity
/
Weighting:
6
Quality criterion
-
Name:
Section O: Clinical outcomes and governance
/
Weighting:
7
Quality criterion
-
Name:
Section P: Patient satisfaction and patient group
/
Weighting:
10
Quality criterion
-
Name:
Section Q: Networks and leadership
/
Weighting:
5
Price
-
Weighting:
0
Value excluding VAT: 4851400.00
GBP
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
48
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
II.2.14)
Additional information
Please note that Lots may have changed from previous publications.
Thrombotic Thrombocytopenic Purpura (TTP) - South West
Lot No:
8
II.2.2)
Additional CPV code(s)
85000000
-
Health and social work services
85100000
-
Health services
II.2.3)
Place of performance
NUTS code:
UKK -
SOUTH WEST (ENGLAND)
II.2.4)
Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
The contracting term for these services will be for a period of up to 4 years
Criteria below
Quality criterion
-
Name:
Section K : Skills and competences
/
Weighting:
20
Quality criterion
-
Name:
Section L: Managing access and treatment pathway
/
Weighting:
42
Quality criterion
-
Name:
Section M: Mobilisation
/
Weighting:
10
Quality criterion
-
Name:
Section N: Education and service continuity
/
Weighting:
6
Quality criterion
-
Name:
Section O: Clinical outcomes and governance
/
Weighting:
7
Quality criterion
-
Name:
Section P: Patient satisfaction and patient group
/
Weighting:
10
Quality criterion
-
Name:
Section Q: Networks and leadership
/
Weighting:
5
Price
-
Weighting:
0
Value excluding VAT: 5634400.00
GBP
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
48
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
II.2.14)
Additional information
Please note that Lots may have changed from previous publications.